Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1 6Phase NA 4Phase 1/2 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 14OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × abiraterone × Clear all
NCT03903835 2025-04-09

ProBio

Karolinska Institutet

Phase 3 Recruiting
750 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT01949337 2023-09-28

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
1,311 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡